Cargando…
Effect of Sacubitril/Valsartan on Neurocognitive Function: Current Status and Future Directions
Sacubitril/valsartan is a new medication approved for the treatment of heart failure with reduced ejection fraction. While the drug failed to meet the primary endpoint in patients with heart failure with preserved ejection fraction in the PARAGON-HF trial, improvements were noted in several secondar...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7561468/ https://www.ncbi.nlm.nih.gov/pubmed/33063249 http://dx.doi.org/10.1007/s40256-020-00445-7 |